Geron reported $-0.03 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -0.03 -0.04 Mar/12 2026
FY2025Q3 Sep/2025 -0.03 -0.03 -0.04 Nov/05 2025
FY2025Q2 Jun/2025 -0.02 -0.03 -0.10 Aug/06 2025
FY2025Q1 Mar/2025 -0.03 -0.03 -0.09 May/07 2025
FY2024Q4 Dec/2024 -0.04 -0.03 -0.09 Feb/26 2025




Eps Change Date
Amgen USD 5.29 0.35 Dec/2025
Bio Techne USD 0.46 0.04 Dec/2025
Cassava Sciences USD -0.22 0.7 Sep/2025
Cytokinetics USD -2.55 1.43 Sep/2025
Exelixis USD 0.78 0.03 Sep/2025
Genmab DKK 34.31 14.07 Jun/2025
Geron USD -0.03 0.01 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Novartis USD 2.04 0.38 Sep/2025